1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Nystatin |
| brand | String | Mycostatin, Nystop, Nyamyc, Bio-Statin |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Polyene_antifungals|Polyene antifungal]] • [[:Category:Antifungals|Antifungal]] |
| mechanism | String | '"`UNIQ--vote-00000D11-QINU`"' Same mechanistic family as amphotericin B but with prohibitive systemic toxicity at therapeutic doses, hence restriction to topical and luminal-gut indications. No clinically meaningful resistance after decades of use'"`UNIQ--ref-00000D12-QINU`"'. |
| uses | String | '"`UNIQ--vote-00000D13-QINU`"', '"`UNIQ--vote-00000D14-QINU`"', '"`UNIQ--vote-00000D15-QINU`"', '"`UNIQ--vote-00000D16-QINU`"' |
| starting_dose | String | Oral: 4-6 mL (400,000-600,000 units) suspension QID swish-and-swallow; topical: BID-QID; vaginal tablet 1 daily for 2 weeks |
| preparations | String | 100,000 units/mL oral suspension; 500,000 unit tablets; 100,000 units/g cream, ointment, powder; vaginal tablets |
| fda_max | String | Indication-specific |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral (topical action; minimal systemic absorption) • topical • vaginal |
| onset | String | Symptom relief within days |
| duration | String | Hours per application |
| halflife | String | Not meaningfully described (not systemically absorbed)'"`UNIQ--ref-00000D17-QINU`"' |
| bioavailability | String | Essentially zero systemic absorption from oral or topical routes — the topical-action-only profile is the basis of its safety'"`UNIQ--ref-00000D18-QINU`"' |
| pregnancy | String | Generally considered safe in pregnancy (no systemic absorption).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
